CERo Therapeutics Holdings Cash Flow Statement 2021-2025 | CERO

Net Income/Loss

$-8.304

$-7.29

$-0.668

$-0.316

Total Depreciation And Amortization - Cash Flow

$1.162

$1.117

Other Non-Cash Items

$-7.61

$-0.158

$-2.837

$-0.017

Total Non-Cash Items

$-6.449

$0.96

$-2.837

$-0.017

Change In Accounts Receivable

Change In Inventories

Change In Accounts Payable

$0.259

$1.281

Change In Assets/Liabilities

$-0.714

$-0.785

$0.175

$-0.38

Total Change In Assets/Liabilities

$1.837

$0.54

$2.412

$-0.365

Cash Flow From Operating Activities

$-12.916

$-5.79

$-1.092

$-0.697

Net Change In Property, Plant, And Equipment

Net Change In Intangible Assets

Net Acquisitions/Divestitures

Net Change In Short-term Investments

$-0.325

Net Change In Long-Term Investments

Net Change In Investments - Total

$-0.325

Investing Activities - Other

$181.164

$-178.5

Cash Flow From Investing Activities

$180.839

$-178.5

Net Long-Term Debt

$-0.02

$0.564

$0.055

Net Current Debt

$0.006

$0.65

$-0.055

Debt Issuance/Retirement Net - Total

$-0.014

$0.564

$0.65

Net Common Equity Issued/Repurchased

$4.81

$0.008

$-139.354

$181.24

Net Total Equity Issued/Repurchased

$13.728

$0.008

$-139.354

$181.24

Total Common And Preferred Stock Dividends Paid

Financial Activities - Other

$0.014

$-0.944

Cash Flow From Financial Activities

$13.728

$0.572

$-138.704

$180.296

Net Cash Flow

$0.812

$-5.218

$41.043

$1.099

Stock-Based Compensation

$0.929

$0.097

Common Stock Dividends Paid